Stay updated on COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Sign up to get notified when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.

Latest updates to the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0, with no visible change to the study record.SummaryDifference0.0%

- Check17 days agoChange DetectedA notice informs visitors that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and provides links to updates and FAQs.SummaryDifference0.2%

- Check24 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check31 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check52 days agoChange DetectedA new revision entry, v3.7.0, appears in the history replacing the previous v3.6.6; this reflects an update to the page's history rather than a change to the study data.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page’s revision indicator in the footer was updated from v3.6.5 to v3.6.6, signaling a small maintenance update to the page version. No user-facing content changes are introduced.SummaryDifference0.0%

Stay in the know with updates to COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib
Enter your email address, and we'll notify you when there's something new on the COMBI-i Clinical Trial: Anti-PD1 + Dabrafenib/Trametinib page.